Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cellebrite DI (CLBT) EBT Margin (2020 - 2025)

Cellebrite DI's EBT Margin history spans 6 years, with the latest figure at 20.39% for Q4 2025.

  • Quarterly EBT Margin rose 215.0% to 20.39% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 19.06% through Dec 2025, up 8785.0% year-over-year, with the annual reading at 19.06% for FY2025, 8785.0% up from the prior year.
  • EBT Margin came in at 20.39% for Q4 2025, up from 19.27% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 87.29% in Q1 2022 to a low of 191.41% in Q3 2024.
  • The 5-year median for EBT Margin is 16.35% (2021), against an average of 0.66%.
  • Year-over-year, EBT Margin plummeted -19955bps in 2024 and then soared 21068bps in 2025.
  • Cellebrite DI's EBT Margin stood at 79.69% in 2021, then tumbled by -85bps to 12.3% in 2022, then crashed by -208bps to 13.27% in 2023, then soared by 237bps to 18.25% in 2024, then increased by 12bps to 20.39% in 2025.
  • Per Business Quant, the three most recent readings for CLBT's EBT Margin are 20.39% (Q4 2025), 19.27% (Q3 2025), and 18.35% (Q2 2025).